Additionally, the cGAS-STING pathway, which is closely connected to the activation of type I IFN and STAT1 pathways, was shown to play a significant role in the vulnerability of SETD2-deficient ccRCC to ATR inhibition (Liu et al., 2023). This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.